A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
Clinical trial NCT05975099 · COMPLETED
Trial details
- NCT number
- NCT05975099
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2025-05-30
- Enrollment
- 807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.